Skip to main content

The independent medical news service

23-02-2021 | Oncology | News | Article

21-gene recurrence score underperforms in Black women with breast cancer

Black women with breast cancer are more likely than non-Hispanic White women to have a high-risk 21-gene Oncotype DX Breast Recurrence Score, and are more likely to die of breast cancer than their non-Hispanic White counterparts with a comparable score, US research shows.

15-02-2021 | Oncology | News | Article

Radiotherapy activity changed significantly during first COVID-19 peak

The total number of radiotherapy courses delivered in England fell significantly during the first peak of the COVID-19 pandemic but this was accompanied by a rapid increase in the use of hypofractionated regimens, study data show.

02-02-2021 | Oncology | News | Article

Psychological distress high in patients with cancer during COVID-19 pandemic

Two independent studies presented at the IASLC 2020 World Conference on Lung Cancer have highlighted the heightened psychological distress experienced by patients with cancer – especially those with lung cancer – during the COVID-19 pandemic.

29-01-2021 | Oncology | News | Article

SOPHIA: Margetuximab boosts HER2-positive advanced breast cancer PFS

Treatment with the novel HER2-targeted agent margetuximab improves the outcomes of heavily pretreated patients with HER2-positive advanced breast cancer, indicate phase 3 trial results.

27-01-2021 | Oncology | News | Article

Population-based risk estimates for breast cancer genes reported

Two analyses have provided population-level estimates of the risk for breast cancer associated with known or suspected susceptibility genes.

25-01-2021 | Oncology | News | Article

Predictive factors for ONJ risk with zoledronic acid identified

The risk for osteonecrosis of the jaw following zoledronic acid treatment in patients with bone metastases is associated with cancer type, oral health, and dosing frequency, US researchers report.

Image Credits